291 related articles for article (PubMed ID: 19166660)
1. Portopulmonary hypertension.
Nayak RP; Li D; Matuschak GM
Curr Gastroenterol Rep; 2009 Feb; 11(1):56-63. PubMed ID: 19166660
[TBL] [Abstract][Full Text] [Related]
2. [Porto-pulmonary hypertension].
Chabot F; Gomez E; Boyer L; Kheir A; Le Pavec J; Sitbon O; Herve P
Rev Mal Respir; 2006 Dec; 23(6):629-41. PubMed ID: 17202968
[TBL] [Abstract][Full Text] [Related]
3. Portopulmonary hypertension: short review.
Stauber RE; Olschewski H
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):385-90. PubMed ID: 19907338
[TBL] [Abstract][Full Text] [Related]
4. Bosentan for the treatment of portopulmonary hypertension.
Tempe DK; Datt V; Datta D
Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
[No Abstract] [Full Text] [Related]
5. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
[TBL] [Abstract][Full Text] [Related]
6. "Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation.
Hoeper MM
Eur Respir Rev; 2011 Dec; 20(122):297-300. PubMed ID: 22130824
[No Abstract] [Full Text] [Related]
7. [Pulmonary hypertension treatment: future prospects].
Baloira A
Arch Bronconeumol; 2007 Mar; 43(3):131-5. PubMed ID: 17386188
[No Abstract] [Full Text] [Related]
8. Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment.
Talwalkar JA; Swanson KL; Krowka MJ; Andrews JC; Kamath PS
Gastroenterology; 2011 Nov; 141(5):1673-9. PubMed ID: 21723219
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension: combination therapy in the modern management era.
Sitbon O
Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195
[No Abstract] [Full Text] [Related]
10. [Pulmonary arterial hypertension and systemic sclerosis].
Launay D; Humbert M; Hachulla E
Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
[TBL] [Abstract][Full Text] [Related]
11. Combination drug therapy in the management of pulmonary arterial hypertension.
Kayser SR
Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142
[No Abstract] [Full Text] [Related]
12. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.
Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA
Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
14. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
Sağ S; Yeşilbursa D; Güllülü S
Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation.
Hemnes AR; Robbins IM
Liver Transpl; 2009 Jan; 15(1):15-9. PubMed ID: 19109843
[TBL] [Abstract][Full Text] [Related]
16. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation.
Raevens S; De Pauw M; Reyntjens K; Geerts A; Verhelst X; Berrevoet F; Rogiers X; Troisi RI; Van Vlierberghe H; Colle I
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):495-502. PubMed ID: 23242127
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension.
He B; Zhang F; Li X; Tang C; Lin G; Du J; Jin H
Circ J; 2010 Jul; 74(7):1458-64. PubMed ID: 20519876
[TBL] [Abstract][Full Text] [Related]
18. Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.
Fussner LA; Krowka MJ
Curr Gastroenterol Rep; 2016 Jun; 18(6):29. PubMed ID: 27098816
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of portopulmonary hypertension.
Medarov BI; Chopra A; Judson MA
Respir Med; 2014 Jul; 108(7):943-54. PubMed ID: 24816204
[TBL] [Abstract][Full Text] [Related]
20. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
